MTHFR and acute lymphoblastic leukemia: In 1999, Skibola et al. [20] first reported that the MTHFR C677T mutation could reduce the susceptibility to adult ALL, and their results suggested that the risk of ALL was reduced by 4.3 times for people carrying the TT genotype.